China Coronavirus Approvals: Fast, Free And Fine?
But Lack Of EUA Could Be A Hindrance
A lack of Emergency Use Authorization potentially jeopardizes China’s efforts to fight the deadly virus outbreak, says a regulatory veteran.
You may also be interested in...
As global buyers rush to order protective face masks, testing kits and ventilators from China, the world's largest medical supplies producer, some manufacturers are refusing to take the orders.
The latest big pharma vote of confidence in both the China market and R&D capabilities comes amid continuing standoffs with the US over a flurry of issues including the coronavirus, national security and trade, but as the pandemic seemingly recedes in China.
From AI-assisted drug discovery to oncotherapy development, China has seen investment pour in over the past week, while the nation's largest online pharmacy is readying for a big Hong Kong debut.